New Release
Abrams' Clinical Drug Therapy
Rationales for Nursing Practice
Edition:
13
ISBN/ISSN:
9781975222321
Publication Date:
January 8, 2024
2024-01-8
9781975222321
Abrams’ Clinical Drug Therapy: Rationales for Nursing Practice, 13th Edition continues a long tradition of guiding students and instructors through ...
Read More
-
-
Abrams’ Clinical Drug Therapy: Rationales for Nursing Practice, 13th Edition continues a long tradition of guiding students and instructors through the practice of safe and effective medication administration. Expert pharmacology educators and clinicians explain the “why” behind each nursing action and emphasize individualized nursing care and drug therapy to promote optimal outcomes in every care setting.
Filled with case studies, concept maps, and other engaging features, this updated 13th Edition reflects an enhanced emphasis on NCLEX® preparation, including practice questions in each chapter and new Clinical Judgment Case Studies in each unit. Drug therapy pertinent to the prevention and treatment of disease is provided in each chapter. Appropriate pathophysiology coverage is now streamlined and more accessible via thePoint®, along with a robust suite of other online resources that reinforce students’ preparation for success in class, on their NCLEX exams, and throughout their nursing careers.
-
Edition13ISBN/ISSN9781975222321Product FormatPaperback BookTrim Size8 3/8 x 10 7/8Pages1288Edition13Publication DateJanuary 8, 2024Weight3.95
-
- Geralyn Frandsen EdD, RN
Assistant Director of Nursing
Professor of Nursing
Catherine McAuley School of Nursing
Maryville University
St. Louis, MO
- SANDRA PENNINGTON
-
- Section 1: The Conceptual Framework of Pharmacology
- Chapter 1: The Foundation of Pharmacology: Quality and Safety
- Chapter 2: Basic Concepts and Processes
- Chapter 3: Medication Administration and the Nursing Process of Drug Therapy
- Section 2: Drug Therapy Throughout the LifespanChapter 4: Pharmacology and the Care of Infants and Pediatric Patients
- Chapter 5: Pharmacology and the Care of Adults and Geriatric Patients
- Chapter 6: Pharmacology and the Care of Pregnant or Lactating Females
- Chapter 7: Pharmacology and Female Health
- Chapter 8: Pharmacology and Male Health
- Section 3: Drugs Affecting the Hematopoietic and Immune Systems
- Chapter 9: Drug Therapy for Coagulation Disorders
- Chapter 10: Drug Therapy for Dyslipidemia
- Chapter 11: Drug Therapy for Hematopoietic Disorders
- Chapter 12: Drug Therapy: Immunizations
- Chapter 13: Drug Therapy to Decrease Immunity
- Chapter 14: Drug Therapy for the Treatment of Cancer
- Section 4: Drugs Affecting Inflammation and Infection
- Chapter 15: Inflammation, Infection, and the Use of Antimicrobial Agents
- Chapter 16: Drug Therapy to Decrease Pain, Fever, and Inflammation
- Chapter 17: Drug Therapy with Corticosteroids
- Chapter 18: Drug Therapy with Beta-Lactam Antibacterial Agents
- Chapter 19: Drug Therapy with Aminoglycosides and Fluoroquinolones
- Chapter 20: Drug Therapy with Tetracyclines, Sulfonamides, and Urinary Antiseptics
- Chapter 21: Drug Therapy with Macrolides and Miscellaneous Anti-Infective Agents
- Chapter 22: Drug Therapy for Tuberculosis and Mycobacterium avium Complex Disease
- Chapter 23: Drug Therapy for Viral Infections
- Chapter 24: Drug Therapy for Fungal Infections
- Chapter 25: Drug Therapy for Parasitic Infections
- Section 5: Drug Affecting the Cardiovascular System
- Chapter 26: Drug Therapy for Hypertension
- Chapter 27: Drug Therapy for Dysrhythmias
- Chapter 28: Drug Therapy for Coronary Heart Disease
- Chapter 29: Drug Therapy for Shock and Hypotension
- Chapter 30: Drug Therapy for Heart Failure
- Section 6: Drugs Affecting the Respiratory System
- Chapter 31: Drug Therapy for Nasal Congestion and Cough
- Chapter 32: Drug Therapy to Decrease Histamine Effects and Allergic Response
- Chapter 33: Drug Therapy for Asthma, Airway Inflammation, and Bronchoconstriction
- Section 7: Drugs Affecting the Renal and Digestive Systems
- Chapter 34: Drug Therapy for Fluid Volume Excess
- Chapter 35: Nutritional Support Products, Vitamins, and Mineral Supplements
- Chapter 36: Drug Therapy for Weight Management
- Chapter 37: Drug Therapy for Peptic Ulcer Disease and Hyperacidity
- Chapter 38: Drug Therapy for Nausea and Vomiting
- Chapter 39: Drug Therapy for Constipation and Elimination Problems
- Chapter 40: Drug Therapy for Diarrhea
- Section 8: Drugs Affecting the Endocrine System
- Chapter 41: Drug Therapy for Diabetes Mellitus
- Chapter 42: Drug Therapy for Hyperthyroidism and Hypothyroidism
- Chapter 43: Drug Therapy for Pituitary and Hypothalamic Dysfunction
- Chapter 44: Drug Therapy to Regulate Calcium and Bone Metabolism
- Chapter 45: Drug Therapy for Adrenal Cortex Disorders
- Section 9: Drugs Affecting the Autonomic and Central Nervous System
- Chapter 46: Physiology of the Autonomic and Central Nervous Systems and Indications for the Use of Drug Therapy
- Chapter 47: Drug Therapy for Myasthenia Gravis, Alzheimer Disease, and Other Conditions Treated with Cholinergic Agents
- Chapter 48: Drug Therapy for Parkinson Disease, Urinary Spasticity, and Disorders Requiring Anticholinergic Drug Therapy
- Chapter 49: Drug Therapy with Opioids
- Chapter 50: Drug Therapy with Local Anesthetics
- Chapter 51: Drug Therapy with General Anesthetics
- Chapter 52: Drug Therapy for Migraines and Other Headaches
- Chapter 53: Drug Therapy for Seizure Disorders and Skeletal Muscle Disorders
- Chapter 54: Drug Therapy for Anxiety and Insomnia
- Chapter 55: Antidepressants and Mood Stabilizers
- Chapter 56: Drug Therapy for Psychotic Disorders
- Chapter 57: Drug Therapy for Attention-Deficit/Hyperactivity Disorder and Narcolepsy
- Chapter 58: Drug Therapy for Substance Use Disorders
- Section 10: Drugs Affecting the Eye, Ear, and Skin
- Chapter 59: Drug Therapy for Disorders of the Eye
- Chapter 60: Drug Therapy for Disorders of the Ear
- Chapter 61: Drug Therapy for Disorders of the Skin
- Section 1: The Conceptual Framework of Pharmacology
-
Safety features
- Quality and Safety Alerts emphasize important considerations regarding patient safety, patient-centered care, and evidence-based practice.
- Black Box warnings alert students to serious or life-threatening adverse effects identified by the FDA for associated drugs.
- Drug Interactions boxes highlight the risk of interactions as well as increased or decreased drug effects when drugs are combined with other medications, herbs, or foods.
Prevention and Health Promotion features- Patient Teaching Guidelines help students better educate patients and families on safe administration of medications, using non-drug treatment alongside or instead of medications, and knowing when to contact their health care provider.
- Nursing Process Concept Maps clarify drug therapy specific to nursing care with succinct overviews of assessment, planning/goals, nursing interventions, and evaluation allowing improved patient education.
- Unfolding Patient Stories, written by the National League for Nursing, inspire reflection and encourages critical thinking.
Building Practice Readiness and NCLEX® Preparation features- NEW! Clinical Application Case Studies open each chapter with a patient-focused clinical scenario and deliver critical decision-making preparation for the Next-Generation NCLEX exam.
- NCLEX Success sections throughout each chapter provide valuable self-assessment and exam practice through NCLEX-style questions.
- Etiology and Pathophysiology information for select diseases available on thePoint reinforces connections with the pharmacologic management of diseases.
USD $124.99
IN STOCK
Quantity:
Buy from another retailer
X
Attention students
Your school may offer this product on Lippincott Direct at a lower price.
Click below and enter your school to see if your courseware is there.
Added To Your Cart
Abrams' Clinical Drug Therapy
ISBN/ISSN: 9781975222321
USD $124.99
Quantity :
Recommended For You
YOU MIGHT ALSO LIKE
